Samuel Kintz
CEO, President at Enliven Therapeutics, Inc. (ELVN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $539K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 19SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 12,500890,392 held (−1%) | $21.82 | $273K | +71.0% |
| Oct 21SEC | ELVNEnliven Therapeutics, Inc. | Sell Plan | 12,500902,892 held (−1%) | $21.33 | $267K | +75.0% |
- Sell
CEO, President Samuel Kintz sold $273K of ELVN at $21.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Samuel Kintz sold $267K of ELVN at $21.33 — pre-scheduled 10b5-1 plan sale.